Internal medicine

Radiology

Hazard ratio

Heart failure

Nuclear medicine

Ejection fraction

Survival analysis

Cardiac function curve

Cardiology

Cardiac PET

Positron emission tomography

Confidence interval

Proportional hazards model

Radiation therapy

Medicine

Journal of Thoracic Oncology

<h2>Abstract</h2><h3>Introduction</h3> Heart dose has emerged as an independent predictor of overall survival in patients with NSCLC treated with radiotherapy. Several studies have identified the base of the heart as a region of enhanced dose sensitivity and a potential target for cardiac sparing. We present a dosimetric analysis of overall survival in the multicenter, randomized PET-Plan trial (NCT00697333) and for the first time include left ventricular ejection fraction (EF) at baseline as a metric of cardiac function. <h3>Methods</h3> A total of 205 patients with inoperable stage II or III NSCLC treated with 60 to 72 Gy in 2 Gy fractions were included in this study. A voxel-wise image-based data mining methodology was used to identify anatomical regions where higher dose was significantly associated with worse overall survival. Univariable and multivariable Cox proportional hazards models tested the association of survival with dose to the identified region, established prognostic factors, and baseline cardiac function. <h3>Results</h3> A total of 172 patients remained after processing and censoring for follow-up. At 2-years posttreatment, a highly significant region was identified within the base of the heart (<i>p</i> < 0.005), centered on the origin of the left coronary artery and the region of the atrioventricular node. In multivariable analysis, the number of positron emission tomography–positive nodes (<i>p</i> = 0.02, hazard ratio = 1.13, 95% confidence interval: 1.02–1.25) and mean dose to the cardiac subregion (<i>p</i> = 0.02, hazard ratio = 1.11 Gy<sup>−1</sup>, 95% confidence interval: 1.02–1.21) were significantly associated with overall survival. There was a significant interaction between EF and region dose (<i>p</i> = 0.04) for survival, with contrast plots revealing a larger effect of region dose on survival in patients with lower EF values. <h3>Conclusions</h3> This work validates previous image-based data mining studies by revealing a strong association between dose to the base of the heart and overall survival. For the first time, an interaction between baseline cardiac health and heart base dose was identified, potentially suggesting preexisting cardiac dysfunction exacerbates the impact of heart dose on survival.

Cardiac Function Modifies the Impact of Heart Base Dose on Survival: A Voxel-Wise Analysis of Patients With Lung Cancer From the PET-Plan Trial